Author:
Steffen R P,Pamnani M B,Clough D L,Huot S J,Muldoon S M,Haddy F J
Abstract
Vanadate, a potent naturally occurring Na+,K+-ATPase inhibitor thought to have a role in regulating Na+-K+ pump activity, was fed to uninephrectomized rats drinking tap water or a 1% solution of sodium chloride for as long as 56 weeks. Feeding was achieved by adding sodium orthovanadate to normal rat chow equivalent to 100 or 200 ppm vanadium by weight. In the rats drinking tap water, systolic pressure gradually increased over a period of several weeks and then was sustained in a dose-related manner for the duration of the treatment. The increased pressure was not associated with changes in water intake, urine output, or urinary sodium excretion but correlated positively with plasma vanadium levels ranging from 0.04 to 0.27 microgram/ml. Increased pressure was associated with increased heart-to-body-weight ratio but did not appear to occur in a small group of animals drinking the 1% solution of sodium chloride. These findings, considered in the light of others, indicate that vanadate deserves continued study in relation to hypertension.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference38 articles.
1. Meisch H-V Bielig H-J: Chemistry and biochemistry of
2. vanadium. Basic Res Cardiol 75: 413 1980
3. Grantham JJ: The renal sodium pump and vanadate. Am J
4. Physiol 239: F97 1980
5. Charney AN Silva P Epstein FH: An in vitro inhibitor of Na
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献